Göteborg University Installs the Geniom® to Enhance Its Genetic Research Capabilities

The Geniom® – the latest generation custom microarray device for flexible analysis of DNA, genes and genomes in a variety of organisms – has been installed at the Göteborg University to enhance their research capability in the area of gene expression profiling.

As a renowned institute in Scandinavia, the Sahlgrenska Academy at the University of Göteborg (Sweden) further expands the European base of installed Geniom devices to seven after the recent installations of two such devices in Leicester (UK).

The Geniom® will further enhance the full range of technical instrumentation available to the Göteborg Scientific Community at the centre for Genomics.

Russell Golson, Director Sales & Service of febit, states “We are delighted to have this community working with our innovative Instrument and look forward to building on our successful relationship with them to date.” During the year 2006 Golson developed a new, scientific sales team.

febit is currently working on preparations for analyzing special organisms applicable for the special interest of several Göteborg-based teams. The ability of Geniom® to detect any known gene of any species within 48 hours in their own laboratory convinced Joakim Larsson, Assistant Professor at Göteborg University, that Geniom® will be a valuable supplement to the interdisciplinary work ongoing in Göteborg: “Geniom® will be useful to us in very diverse areas, anywhere from cancer research on human cells all the way to environmental research on fish or even complex microbial communities. Personally, my main interest is environmental effects of pharmaceuticals on wildlife. Together with our present infrastructure for proteomic and metabolomic analyses, Geniom® will contribute strongly to our possibilities to develop molecular biomarkers and increase our understanding of the mode of actions of human drugs in non-target species.”

The Geniom® platform was generously donated by the Lundberg foundation in a grant awarded to Professor Tommy Nilsson, Institute of Biomedicine (SA, GU). “We have already broken new grounds in profiling low abundance mRNAs encoding for glycosylation enzymes associated with breast cancer” says Professor Nilsson, “An instrument of this capability must therefore be available to as many researchers as possible, which is why it is placed in the centre for Genomics. I am sure we will see a lot of exciting research coming out of this platform. ”